as mentioned in businessinsider
Johnson & Johnson CSO on the future of HIV vaccine
Johnson & Johnson CSO on the future of HIV vaccine
Over the past 35 years, the way researchers have approached HIV has shifted.Now, with advancements in the way HIV is treated, the focus has shifted earlier and earlier on prevention efforts.Business Insider spoke with Johnson & Johnson's chief scientific officer, Paul Stoffels, whose company is working on trials for an HIV vaccine, as well as a long-acting injectable form of HIV medication that could replace daily pills with a shot taken on a monthly basis.
additionally naij
South Africa will start trials of vaccine against HIV this year ▷ ASK.NAIJ
South Africa will start trials of vaccine against HIV this year ▷ ASK.NAIJ
Have you heard of the latest HIV vaccine news?It looks like African people have a chance to get rid of the epidemic!Find out more about it here!
//www.youtube.com/embed/bfOyL9jkEho?rel=0
additionally fiercepharma
Texas Biomed leads transatlantic group in $23M HIV vaccine effort
Texas Biomed leads transatlantic group in $23M HIV vaccine effort
An HIV vaccine research team led by Texas Biomedical Research Institute has secured $23 million in NIH grant funding to explore an approach that'll utilize three lines of defense to protect against the virus.As part of the 5-year project with three phases, the scientists want to develop a vaccine that can block HIV where it infiltrates the body at the mucosa while also creating a backup response throughout the blood and tissue.First, the group will examine how HIV moves through mucus and mucosal fluids and how it passes through epithelial barriers.
coupled with businessinsider
Johnson & Johnson CSO on the future of HIV vaccine
Johnson & Johnson CSO on the future of HIV vaccineOver the past 35 years, the way researchers have approached HIV has shifted.Now, with advancements in the way HIV is treated, the focus has shifted earlier and earlier on prevention efforts.Business Insider spoke with Johnson & Johnson's chief scientific officer, Paul Stoffels, whose company is working on trials for an HIV vaccine, as well as a long-acting injectable form of HIV medication that could replace daily pills with a shot taken on a monthly basis.
No comments:
Post a Comment